Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. / Dall, Morten; Hassing, Anna S.; Niu, Lili; Nielsen, Thomas S.; Ingerslev, Lars R.; Sulek, Karolina; Trammell, Samuel A.J.; Gillum, Matthew P.; Barrès, Romain; Larsen, Steen; Poulsen, Steen S.; Mann, Matthias; Ørskov, Cathrine; Treebak, Jonas T.

In: Journal of Biological Chemistry, Vol. 297, No. 6, 101388, 2021.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Dall, M, Hassing, AS, Niu, L, Nielsen, TS, Ingerslev, LR, Sulek, K, Trammell, SAJ, Gillum, MP, Barrès, R, Larsen, S, Poulsen, SS, Mann, M, Ørskov, C & Treebak, JT 2021, 'Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes', Journal of Biological Chemistry, vol. 297, no. 6, 101388. https://doi.org/10.1016/j.jbc.2021.101388

APA

Dall, M., Hassing, A. S., Niu, L., Nielsen, T. S., Ingerslev, L. R., Sulek, K., Trammell, S. A. J., Gillum, M. P., Barrès, R., Larsen, S., Poulsen, S. S., Mann, M., Ørskov, C., & Treebak, J. T. (2021). Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. Journal of Biological Chemistry, 297(6), [101388]. https://doi.org/10.1016/j.jbc.2021.101388

Vancouver

Dall M, Hassing AS, Niu L, Nielsen TS, Ingerslev LR, Sulek K et al. Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. Journal of Biological Chemistry. 2021;297(6). 101388. https://doi.org/10.1016/j.jbc.2021.101388

Author

Dall, Morten ; Hassing, Anna S. ; Niu, Lili ; Nielsen, Thomas S. ; Ingerslev, Lars R. ; Sulek, Karolina ; Trammell, Samuel A.J. ; Gillum, Matthew P. ; Barrès, Romain ; Larsen, Steen ; Poulsen, Steen S. ; Mann, Matthias ; Ørskov, Cathrine ; Treebak, Jonas T. / Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes. In: Journal of Biological Chemistry. 2021 ; Vol. 297, No. 6.

Bibtex

@article{25c9a01549914c7d8b21aa8995fec3a0,
title = "Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes",
abstract = "Nicotinamide phosphoribosyltransferase (NAMPT) converts nicotinamide to NAD+. As low hepatic NAD+ levels have been linked to the development of nonalcoholic fatty liver disease, we hypothesized that ablation of hepatic Nampt would affect susceptibility to liver injury in response to diet-induced metabolic stress. Following 3 weeks on a low-methionine and choline-free 60% high-fat diet, hepatocyte-specific Nampt knockout (HNKO) mice accumulated less triglyceride than WT littermates but had increased histological scores for liver inflammation, necrosis, and fibrosis. Surprisingly, liver injury was also observed in HNKO mice on the purified control diet. This HNKO phenotype was associated with decreased abundance of mitochondrial proteins, especially proteins involved in oxidoreductase activity. High-resolution respirometry revealed lower respiratory capacity in purified control diet- fed HNKO liver. In addition, fibrotic area in HNKO liver sections correlated negatively with hepatic NAD+, and liver injury was prevented by supplementation with NAD+ precursors nicotinamide riboside and nicotinic acid. MS-based proteomic analysis revealed that nicotinamide riboside supplementation rescued hepatic levels of oxidoreductase and OXPHOS proteins. Finally, single-nucleus RNA-Seq showed that transcriptional changes in the HNKO liver mainly occurred in hepatocytes, and changes in the hepatocyte transcriptome were associated with liver necrosis. In conclusion, HNKO livers have reduced respiratory capacity, decreased abundance of mitochondrial proteins, and are susceptible to fibrosis because of low NAD+ levels. Our data suggest a critical threshold level of hepatic NAD+ that determines the predisposition to liver injury and supports that NAD+ precursor supplementation can prevent liver injury and nonalcoholic fatty liver disease progression.",
author = "Morten Dall and Hassing, {Anna S.} and Lili Niu and Nielsen, {Thomas S.} and Ingerslev, {Lars R.} and Karolina Sulek and Trammell, {Samuel A.J.} and Gillum, {Matthew P.} and Romain Barr{\`e}s and Steen Larsen and Poulsen, {Steen S.} and Matthias Mann and Cathrine {\O}rskov and Treebak, {Jonas T.}",
note = "Publisher Copyright: {\textcopyright} 2021 THE AUTHORS.",
year = "2021",
doi = "10.1016/j.jbc.2021.101388",
language = "English",
volume = "297",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology, Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes

AU - Dall, Morten

AU - Hassing, Anna S.

AU - Niu, Lili

AU - Nielsen, Thomas S.

AU - Ingerslev, Lars R.

AU - Sulek, Karolina

AU - Trammell, Samuel A.J.

AU - Gillum, Matthew P.

AU - Barrès, Romain

AU - Larsen, Steen

AU - Poulsen, Steen S.

AU - Mann, Matthias

AU - Ørskov, Cathrine

AU - Treebak, Jonas T.

N1 - Publisher Copyright: © 2021 THE AUTHORS.

PY - 2021

Y1 - 2021

N2 - Nicotinamide phosphoribosyltransferase (NAMPT) converts nicotinamide to NAD+. As low hepatic NAD+ levels have been linked to the development of nonalcoholic fatty liver disease, we hypothesized that ablation of hepatic Nampt would affect susceptibility to liver injury in response to diet-induced metabolic stress. Following 3 weeks on a low-methionine and choline-free 60% high-fat diet, hepatocyte-specific Nampt knockout (HNKO) mice accumulated less triglyceride than WT littermates but had increased histological scores for liver inflammation, necrosis, and fibrosis. Surprisingly, liver injury was also observed in HNKO mice on the purified control diet. This HNKO phenotype was associated with decreased abundance of mitochondrial proteins, especially proteins involved in oxidoreductase activity. High-resolution respirometry revealed lower respiratory capacity in purified control diet- fed HNKO liver. In addition, fibrotic area in HNKO liver sections correlated negatively with hepatic NAD+, and liver injury was prevented by supplementation with NAD+ precursors nicotinamide riboside and nicotinic acid. MS-based proteomic analysis revealed that nicotinamide riboside supplementation rescued hepatic levels of oxidoreductase and OXPHOS proteins. Finally, single-nucleus RNA-Seq showed that transcriptional changes in the HNKO liver mainly occurred in hepatocytes, and changes in the hepatocyte transcriptome were associated with liver necrosis. In conclusion, HNKO livers have reduced respiratory capacity, decreased abundance of mitochondrial proteins, and are susceptible to fibrosis because of low NAD+ levels. Our data suggest a critical threshold level of hepatic NAD+ that determines the predisposition to liver injury and supports that NAD+ precursor supplementation can prevent liver injury and nonalcoholic fatty liver disease progression.

AB - Nicotinamide phosphoribosyltransferase (NAMPT) converts nicotinamide to NAD+. As low hepatic NAD+ levels have been linked to the development of nonalcoholic fatty liver disease, we hypothesized that ablation of hepatic Nampt would affect susceptibility to liver injury in response to diet-induced metabolic stress. Following 3 weeks on a low-methionine and choline-free 60% high-fat diet, hepatocyte-specific Nampt knockout (HNKO) mice accumulated less triglyceride than WT littermates but had increased histological scores for liver inflammation, necrosis, and fibrosis. Surprisingly, liver injury was also observed in HNKO mice on the purified control diet. This HNKO phenotype was associated with decreased abundance of mitochondrial proteins, especially proteins involved in oxidoreductase activity. High-resolution respirometry revealed lower respiratory capacity in purified control diet- fed HNKO liver. In addition, fibrotic area in HNKO liver sections correlated negatively with hepatic NAD+, and liver injury was prevented by supplementation with NAD+ precursors nicotinamide riboside and nicotinic acid. MS-based proteomic analysis revealed that nicotinamide riboside supplementation rescued hepatic levels of oxidoreductase and OXPHOS proteins. Finally, single-nucleus RNA-Seq showed that transcriptional changes in the HNKO liver mainly occurred in hepatocytes, and changes in the hepatocyte transcriptome were associated with liver necrosis. In conclusion, HNKO livers have reduced respiratory capacity, decreased abundance of mitochondrial proteins, and are susceptible to fibrosis because of low NAD+ levels. Our data suggest a critical threshold level of hepatic NAD+ that determines the predisposition to liver injury and supports that NAD+ precursor supplementation can prevent liver injury and nonalcoholic fatty liver disease progression.

U2 - 10.1016/j.jbc.2021.101388

DO - 10.1016/j.jbc.2021.101388

M3 - Journal article

C2 - 34762911

AN - SCOPUS:85120783047

VL - 297

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 6

M1 - 101388

ER -

ID: 287758766